Fidelity Investments’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974M Buy
11,699,950
+2,771,376
+31% +$219M 0.05% 305
2025
Q4
$695M Buy
8,928,574
+3,048,963
+52% +$206M 0.04% 396
2025
Q3
$333M Buy
5,879,611
+447,617
+8% +$20.2M 0.02% 652
2025
Q2
$237M Buy
5,431,994
+1,022,760
+23% +$35.2M 0.01% 755
2025
Q1
$121M Sell
4,409,234
-421,189
-9% -$15.4M 0.01% 1015
2024
Q4
$194M Sell
4,830,423
-278,718
-5% -$12.6M 0.01% 835
2024
Q3
$242M Buy
5,109,141
+282,301
+6% +$12.5M 0.01% 761
2024
Q2
$144M Buy
4,826,840
+462,430
+11% +$16M 0.01% 905
2024
Q1
$175M Buy
4,364,410
+3,829,810
+716% +$137M 0.01% 841
2023
Q4
$13.6M Sell
534,600
-335,947
-39% -$6.01M ﹤0.01% 1743
2023
Q3
$12.1M Buy
870,547
+32,335
+4% +$650K ﹤0.01% 1770
2023
Q2
$19.3M Buy
838,212
+170,861
+26% +$4.9M ﹤0.01% 1654
2023
Q1
$19.8M Sell
667,351
-178,695
-21% -$5.76M ﹤0.01% 1611
2022
Q4
$21.1M Buy
846,046
+520,360
+160% +$13.9M ﹤0.01% 1593
2022
Q3
$7.09M Sell
325,686
-21,098
-6% -$556K ﹤0.01% 2045
2022
Q2
$6.83M Sell
346,784
-1,577,105
-82% -$36.8M ﹤0.01% 2131
2022
Q1
$81.4M Sell
1,923,889
-423,638
-18% -$17.9M 0.01% 1163
2021
Q4
$149M Sell
2,347,527
-8,280
-0.4% -$482K 0.01% 913
2021
Q3
$138M Buy
2,355,807
+173,378
+8% +$10.1M 0.01% 970
2021
Q2
$106M Sell
2,182,429
-169,909
-7% -$7.38M 0.01% 1101
2021
Q1
$91.4M Sell
2,352,338
-89,722
-4% -$5.4M 0.01% 1106
2020
Q4
$151M Buy
2,442,060
+180,592
+8% +$8.81M 0.01% 863
2020
Q3
$73.1M Buy
+2,261,468
New +$69M 0.01% 1056

Other funds holding KYMR